Cargando…

Drug-Induced Liver Injury After Soy Protein Supplement Use

Drug-induced liver injury (DILI) is an important and often elusive cause of iatrogenic hepatic injury which complicates its recognition and treatment. We describe a rare case of severe liver injury in a previously healthy individual associated with a commonly used and reportedly safe soy protein pow...

Descripción completa

Detalles Bibliográficos
Autores principales: Pillai, Ajish, Thapar, Manish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Gastroenterology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435388/
https://www.ncbi.nlm.nih.gov/pubmed/26157956
http://dx.doi.org/10.14309/crj.2015.47
_version_ 1782371914461741056
author Pillai, Ajish
Thapar, Manish
author_facet Pillai, Ajish
Thapar, Manish
author_sort Pillai, Ajish
collection PubMed
description Drug-induced liver injury (DILI) is an important and often elusive cause of iatrogenic hepatic injury which complicates its recognition and treatment. We describe a rare case of severe liver injury in a previously healthy individual associated with a commonly used and reportedly safe soy protein powder supplement. Discontinuation of the supplements and initiation of ursodeoxycholic acid provided symptomatic relief, decreased pruritus, and resulted in a resolution of hepatic panel labs.
format Online
Article
Text
id pubmed-4435388
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American College of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-44353882015-07-08 Drug-Induced Liver Injury After Soy Protein Supplement Use Pillai, Ajish Thapar, Manish ACG Case Rep J Case Report Drug-induced liver injury (DILI) is an important and often elusive cause of iatrogenic hepatic injury which complicates its recognition and treatment. We describe a rare case of severe liver injury in a previously healthy individual associated with a commonly used and reportedly safe soy protein powder supplement. Discontinuation of the supplements and initiation of ursodeoxycholic acid provided symptomatic relief, decreased pruritus, and resulted in a resolution of hepatic panel labs. American College of Gastroenterology 2015-04-10 /pmc/articles/PMC4435388/ /pubmed/26157956 http://dx.doi.org/10.14309/crj.2015.47 Text en Copyright © Pillai et al. This is an open-access article. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Case Report
Pillai, Ajish
Thapar, Manish
Drug-Induced Liver Injury After Soy Protein Supplement Use
title Drug-Induced Liver Injury After Soy Protein Supplement Use
title_full Drug-Induced Liver Injury After Soy Protein Supplement Use
title_fullStr Drug-Induced Liver Injury After Soy Protein Supplement Use
title_full_unstemmed Drug-Induced Liver Injury After Soy Protein Supplement Use
title_short Drug-Induced Liver Injury After Soy Protein Supplement Use
title_sort drug-induced liver injury after soy protein supplement use
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435388/
https://www.ncbi.nlm.nih.gov/pubmed/26157956
http://dx.doi.org/10.14309/crj.2015.47
work_keys_str_mv AT pillaiajish druginducedliverinjuryaftersoyproteinsupplementuse
AT thaparmanish druginducedliverinjuryaftersoyproteinsupplementuse